Complete FDA and NHTSA recall records dated in August 2025.
These records include useful source details for the selected month.
Product may contain small metal fragments due to contaminated onion powder ingredient used in manufacturing.
Potential presence of glass pieces
Various snack cracker products are mislabeled and do not declare all allergen ingredients (Whole Milk Powder and wheat).
Various snack cracker products are mislabeled and do not declare all allergen ingredients (Whole Milk Powder and wheat).
Tuna Salad products are recalled due to potential contamination with Listeria monocytogenes because products containing Newly Weds Foods recalled Japanese Style Breadcrumbs.
Downstream recall of a dietary supplement ingredient that was manufactured out of specification.
4% Lithium Orotate product may only contain 3% and 9% Lithium Orotate product may contain 4.45%
Tuna Salad products are recalled due to potential contamination with Listeria monocytogenes because products containing Newly Weds Foods recalled Japanese Style Breadcrumbs.
Frozen Oyster product is potentially contaminated with Norovirus
Various snack cracker products are mislabeled and do not declare all allergen ingredients (Whole Milk Powder and wheat).
Product may contain small metal fragments due to contaminated onion powder ingredient used in manufacturing.
Product was manufactured and held under insanitary conditions. Product may be contaminated with Listeria monocytogenes.
Potential contamination with foreign objects (metal pieces).
Tuna Salad products are recalled due to potential contamination with Listeria monocytogenes because products containing Newly Weds Foods recalled Japanese Style Breadcrumbs.
Tuna Salad products are recalled due to potential contamination with Listeria monocytogenes because products containing Newly Weds Foods recalled Japanese Style Breadcrumbs.
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval,…
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
